CARDIFF ONCOLOGY INC (CRDF)
US14147L1089 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -41.44M | -38.70M | -28.29M | -19.31M | -16.41M | |||
| Depreciation Amortization | 398.00K | 240.00K | 450.00K | 470.00K | 490.00K | |||
| Change In Working Capital | 6.57M | -380.00K | -1.79M | -650.00K | 1.09M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Taxes Paid | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 3.59M | 5.03M | 6.59M | 3.18M | 1.56M | |||
| OPERATING CASH FLOW | -30.89M | -33.82M | -23.04M | -16.31M | -13.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -582.00K | -1.01M | -210.00K | -210.00K | -70.00K | |||
| Other Investing Activity | 36.78M | 39.16M | -131.24M | N/A | 0.00 | |||
| INVESTING CASH FLOW | 36.20M | 38.15M | -131.45M | -210.00K | -70.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 0.00 | 80.00K | 35.45M | 137.32M | 12.12M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -10.00K | -40.00K | |||
| FINANCING CASH FLOW | 0.00 | 80.00K | 35.45M | 137.31M | 12.08M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 5.31M | 4.41M | -119.04M | 120.79M | -1.26M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.89M | -33.82M | -23.04M | -16.31M | -13.27M | |||
| Capital Expenditure | -582.00K | -1.01M | -210.00K | -210.00K | -70.00K | |||
| FREE CASH FLOW | -31.47M | -34.83M | -23.25M | -16.52M | -13.34M | |||
All data in USD